Juverderm Ultra

 

PARENTHESES HAVE A PLACE, BUT NOT ON YOUR FACE

 

How parantheses appear...

As you age, your skin changes. For example, it reduces production of a naturally hydrating substance called hyaluronic acid (HA). Over time, the loss of HA in your skin results in facial wrinkles and folds, like those "parentheses" lines around your mouth.

...and disappear

JUVEDERM injectable gel replaces the HA your skin has lost, bringing back its volume and smoothing away facial wrinkles and folds. A breakthrough in HA dermal fillers, JUVEDERM is the first smooth-consistency HA gel and only HA filler FDA approved to last up to a year!

                      

Everyone will notice, but no one will know

You can experience the benefits of JUVEDERM injectable gel in a quick, in-office procedure. Your healthcare professional eases JUVEDERM under your skin to instantly smooth out the wrinkles and folds on your face. You'll see the difference immediately!

What makes JUVEDERM different?

While other HA fillers on the market have a more granular consistency, JUVEDERM injectable gel is the first smooth-consistency HA gel. This is due to an innovative manufacturing process called HYLACROSS technology. HYLACROSS gives JUVEDERM its unique smooth-gel properties as well as an optimal gel structure that holds up over time.

High patient preference

When JUVEDERM was tested in a clinical setting among people who didn't know which filler they were getting, nearly 90% stated a preference for JUVEDERM! In addition, JUVEDERM injectable gel has been tested on all skin phototypes, both male and female, so everyone can enjoy the benefits of JUVEDERM.

What you can expect during and after JUVEDERM injectable gel treatment

Wrinkle correction with JUVEDERM is a quick, in-office procedure with immediate results and no downtime.

Common side effects with JUVEDERM injectable gel usually are mild or moderate. Ask your healthcare professional how to manage them.

JUVEDERM injectable gel
Important treatment considerations for patients

In the US, JUVEDERM injectable gel is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) and is generally well tolerated. The most commonly reported side effects are temporary injection site redness, swelling, pain/tenderness, firmness, lumps/bumps, and bruising. Exposure of the treated area to excessive sun and extreme cold weather should be minimized until any initial swelling and redness have resolved. If laser treatment, chemical peel, or any other procedure based on active dermal response is considered after treatment with JUVEDERM injectable gel, there is a possible risk of an inflammatory reaction at the treatment site.

Patients who are using substances that can prolong bleeding, such as aspirin or ibuprofen, as with any injection, may experience increased bruising or bleeding at injection site. You should inform your physician before treatment if you are using these types of substances. As with all skin-injection procedures, there is a rick of infection. JUVEDERM injectable gel should be used with caution in patients on immunosuppressive therapy, or therapy used to decrease the body's immune response, as there may be an increased risk of infection. The safety of JUVEDERM injectable gel in patients with a history of excessive scarring (eg, hypertrophic scarring and keloid formations) and pigmentation disorders has not been studied.

JUVEDERM injectable gel should not be used in patients who have sensitive allergies marked by a history of anaphylaxis or history or presence of multiple severe allergies. JUVEDERM injectable gel should not be used in patients with a history of allergies to Gram-positive bacterial proteins. The safety of JUVEDERM injectable gel for use during pregnancy, in breastfeeding females, or in patients under 18 years has not been  established. The safety and effectiveness of JUVEDERM injectable gel for the treatment of areas other than facial wrinkles and folds (such as lips) have not been established in controlled clinical studies.

 

ACCESSIBILITY